These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8905554)

  • 1. Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy.
    Imrie HJ; McGonigle TP; Liu DT; Jones DR
    J Reprod Immunol; 1996 Oct; 31(3):221-7. PubMed ID: 8905554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
    Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
    Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.
    Blanchard D; Navenot JM; Petit-Le Roux Y; Willem C; Loirat MJ
    Transfus Clin Biol; 1997; 4(1):131-4. PubMed ID: 9095519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
    Terstappen LW; Nguyen M; Lazarus HM; Medof ME
    J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-irradiation does not affect the levels of complement regulatory proteins, CD35 (CR1), CD55 (DAF) and CD59 on concentrated red cells.
    Fukumori Y; Seya T; Ohnoki S; Shibata H; Yamaguchi H
    Vox Sang; 1996; 71(4):243-4. PubMed ID: 8958650
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS.
    Pascual M; Danielsson C; Steiger G; Schifferli JA
    Eur J Immunol; 1994 Mar; 24(3):702-8. PubMed ID: 7510241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.
    Leslie RG
    Immunology; 1999 Jul; 97(3):371-3. PubMed ID: 10447756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunosorbent assay for complement regulatory proteins and membrane-bound immunoglobulins on intact red blood cells.
    Jones DR; Thompson RJ; Rao SA; Imrie H
    J Immunol Methods; 1994 Dec; 177(1-2):235-42. PubMed ID: 7529808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA).
    Arora M; Kumar A; Das SN; Srivastava LM
    Clin Exp Immunol; 1998 Jan; 111(1):102-6. PubMed ID: 9472668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
    Shapiro S; Kohn D; Miller B; Gershon H
    Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia & expression levels of CD35, CD55 & CD59 on red blood cells in Plasmodium falciparum malaria patients from India.
    Mahajan RC; Narain K; Mahanta J
    Indian J Med Res; 2011 Jun; 133(6):662-4. PubMed ID: 21727667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.
    Owuor BO; Odhiambo CO; Otieno WO; Adhiambo C; Makawiti DW; Stoute JA
    Mol Med; 2008; 14(3-4):89-97. PubMed ID: 18317566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
    Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
    Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression and mobilisation of the complement regulatory proteins CD35, CD55 and CD59 in neonatal and adult neutrophils.
    Lothian C; Dahlgren C; Lagercrantz H; Lundahl J
    Biol Neonate; 1997; 72(1):15-21. PubMed ID: 9313830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).
    Chen CH; Ghiran I; Beurskens FJ; Weaver G; Vincent JA; Nicholson-Weller A; Klickstein LB
    Clin Exp Immunol; 2007 Jun; 148(3):546-54. PubMed ID: 17493021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF.
    Hara T; Matsumoto M; Fukumori Y; Miyagawa S; Hatanaka M; Kinoshita T; Seya T; Akedo H
    Immunol Lett; 1993 Aug; 37(2-3):145-52. PubMed ID: 7505002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.